$ATR

Tlili Hedi sold $1.2M of ATR

Tlili Hedi (Segment President) sold 8,854 shares of APTARGROUP, INC. (ATR) at $135.00 ($1.20M total) on 2026-08-03.

Original reporting
SEC EDGAR · Tlili Hedi
Published Aug 3, 2026, 11:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 11:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATR
Neutral
medium confidence
Mentioned
$ATR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRNeutralLow
01

Why it matters

This provides a fresh datapoint on insider selling activity but does not include any new operational, financial, or regulatory development for the company.

02

Market read

Traders may note insider selling as a sentiment input, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Insider sales can be driven by diversification, planned expenses, or pre-existing personal circumstances; without follow-on buys/sales patterns, signal quality is low.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-03, transaction dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for AptarGroup, Inc. (ATR).

Company-level read

Ticker impact

$ATRNeutralMedium confidence
Context

SEC Form 4 shows insider Tlili Hedi, Segment President at AptarGroup, sold 8,854 shares at $135 on 2026-08-03.

Expected impact

Likely limited, short-lived sentiment impact; no clear directional signal without broader context.

Evidence & confidence

Form 4 insider sales are common and the article provides no accompanying guidance, deal, or operational change. The transaction is sizable in dollars but lacks evidence of new company-specific fundamentals.

Market effects

No sector-level implications; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale could be routine liquidity or tax-related, especially with no 10b5-1 plan cited, so it may not reflect bearish fundamentals.

Key entities

  • AptarGroup, Inc.

    Company subject of the Form 4 insider transaction disclosure.

  • Tlili Hedi

    Segment President who sold shares via an open-market sale.

Related articles

$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 atr-20260630x8kexx991.htm EX-99.1 Document Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing,